|Bid||5.33 x 1100|
|Ask||5.35 x 1000|
|Day's Range||5.28 - 5.86|
|52 Week Range||1.49 - 7.72|
|Beta (5Y Monthly)||-0.74|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 14, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.67|
Genprex, Inc. Announces $25 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules, Without Warrants
Let's get out the magnifying glass and examine GNPX's selling of 4 million shares and the hit it took on Tuesday.
Genprex forms a Clinical Advisory Board.